ORKA-001, Placebo for ORKA-001
ORKA-001-114
Phase 2 small_molecule active
Quick answer
ORKA-001, Placebo for ORKA-001 for Moderate-to-Severe Plaque Psoriasis is a Phase 2 program (small_molecule) at Oruka Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Oruka Therapeutics
- Indication
- Moderate-to-Severe Plaque Psoriasis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active